1.Objective To synthetical analyse the current status of medication in portal hypertension (PHT) and the direction of development.
目的综合分析国内外门静脉高压症的药物治疗现状及发展方向。
2.Objective To summarize the experience of managing portal hypertension( PHT) complicated with hyperthyroidism.
目的总结合并甲状腺机能亢进（简称甲亢）的门静脉高压病人的处理经验。
3.OBJECTIVE: Phenytoin (PHT) is widely administered after subarachnoid hemorrhage, often for several weeks or months.
背景：苯妥英钠（PHT）在蛛网膜下腔出血后被广泛地应用，经常应用数周或数月。
4.Short-term PHT administration may be a superior treatment paradigm.
短期PHT治疗也许是一个比较好的治疗方法。
5.Besides, longer PC-Records and larger PHT capacity can reduce more miss prediction percentage for primary predictor in general.
而且在一般情况下，随着记录式结构PC记录的长度变长和PHT容量增大，记录式结构能够减少更多的预测错误比例。
6.Objective: To evaluate the situation of combined operation in preventive operation for portal hypertension (PHT).
目的：探讨联合手术在门静脉高压症病人预防性手术中的地位。
7.Methods: Through PHT model in rats, we dynamically observed the changes in the SOD level in venous plasma.
方法：通过门脉高压症大鼠模型，我们动态观测血清中超氧化物歧化酶含量变化。
8.Conclusion This method can establish a stable cirrhosis PHT model, which can be made in large quantities.
结论本体例可成立不变的肝硬化门脉高压症模子，且适于多量量建造；
9.CONCLUSION: A 3-day regimen of PHT prophylaxis is adequate to prevent seizures in subarachnoid hemorrhage patients.
结论：PHT3天疗程法可以充分地预防蛛网膜下腔出血患者癫痫发作，且药物反应显著下降。
10.AIM: To study the effect of levofloxacin(LVFX)on serum concentrations and pharmacokinetics of phenytoin sodium(PHT)in rabbits.
目的：研究左旋氧氟沙星对苯妥英钠血药浓度及药代动力学参数的影响。